
    
      The purpose of study is to determine if Varenicline (Chantix™) promotes cocaine abstinence in
      cocaine dependent individuals. Varenicline (Chantix™) (2.0 mg/day) or placebo will be
      administered in a 9-week double-blind trial to patients meeting diagnostic criteria for
      cocaine dependence.
    
  